Meanwhile, hemoglobin (HBA1, HBB or HBD) was not significantly differential between high‐risk adenomas and controls, and subsequently it was not selected in any of the biomarker panels, which is in line with the limited sensitivity of FIT for adenomas. This evidence concerns the gene HBA1 and adenoma.